BackBetter Therapeutics- Tradeable Rights - March 2021 Overview

Better Therapeutics- Tradeable Rights - March 2021 Total Assets

Track Better Therapeutics- Tradeable Rights - March 2021's total assets ($11M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$10.72M
↓ 62.01% YoYΔ $-17.50M vs prior year quarter

Peer trimmed avg / median

Loading

Better Therapeutics- Tradeable Rights - March 2021 Total Assets History

Loading

Better Therapeutics- Tradeable Rights - March 2021 vs. peers: Total Assets Comparison

Loading

Better Therapeutics- Tradeable Rights - March 2021 Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Better Therapeutics- Tradeable Rights - March 2021 (MCADR) FAQ

As of the most recent data (September 2023), MCADR shows a total assets of $11M. That compares with $28M in the prior-year period — down 62.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, MCADR's total assets is now $11M (was $28M) — a 62.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Better Therapeutics- Tradeable Rights - March 2021 is outperforming or lagging.

Tracking MCADR's total assets over time shows whether Better Therapeutics- Tradeable Rights - March 2021 is scaling, shrinking, or reshaping that part of the business. The current reading is $11M That compares with $28M in the prior-year period — down 62.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has Better Therapeutics- Tradeable Rights - March 2021's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $11M) with ownership activity and broader fundamentals.